John M. Goldman

John M. Goldman, who lived from 30 November 1938 to 24 December 2013, was a British haematologist, oncologist and medical researcher who specialized in chronic myeloid leukaemia. Born in London to parents who were Jewish refugees from Nazi Germany, he studied at Magdalen College, Oxford, and trained and taught in haematology and oncology at several schools and hospitals, among them St. Bartholomew's Hospital, Harvard and the University of Miami. He joined the staff of Hammersmith Hospital in London in 1971. In the 1980s he carried out some of the first bone marrow transplants in Europe and developed sensitive molecular tests that detect residual leukaemia cells in a patient's blood. From the late 1990s he helped refine and promote clinical use of the targeted drug imatinib. He chaired the charity Leuka from its start in 1982, worked for the Anthony Nolan register for more than twenty years, helped found the World Marrow Donor Association in 1990, and edited the journal Bone Marrow Transplantation from 1985 until his death.